View in EDS

Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence.

Saved in:

Bibliographic Details
Title:	Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence.
Authors:	Lombardi G; Laboratory of Experimental Biochemistry and Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italia., Perego S; Laboratory of Experimental Biochemistry and Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italia., Sansoni V; Laboratory of Experimental Biochemistry and Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italia., Diani M; Department of Dermatology and Venereology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italia., Banfi G; Laboratory of Experimental Biochemistry and Molecular Biology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italia.; Vita-Salute San Raffaele University, Milano, Italia., Altomare G; Department of Dermatology and Venereology, I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, Italia.; Department of Biomedical Sciences for Health, University of Milano, Milano, Italia.
Source:	BMJ open [BMJ Open] 2016 Dec 09; Vol. 6 (12), pp. e011941. Date of Electronic Publication: 2016 Dec 09.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2044-6055
DOI:	10.1136/bmjopen-2016-011941